AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17906163
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with doxazosin (4 mg/d)
Trial: 17906163
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with tamsulosin (0.4 mg/d)
Trial: 17906163
Drug: Doxazosin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (4 mg/d) with placebo
Trial: 9451062
Drug: 7.2% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.2% saline solution
Trial: 7658056
Drug: Aerosolized pentamidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine, 300 mg every month
Trial: 7658056
Drug: Dapsone, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone, 50 mg/day
Trial: 2684251
Drug: Extradural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extradural clonidine (EC) 2 micrograms kg‐1 in isotonic saline solution 15 micrograms ml‐1
Trial: 2684251
Drug: Extradural saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural saline (ES) equivalent volume of plain isotonic saline solution
Trial: 24135389
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + Rosiglitazone
Trial: 29654849
Drug: Insulin regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin regimens (short or long-acting)
Trial: 23426461
Drug: teduglutide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teduglutide (0.5 mg/kg/d)
Trial: 23426461
Drug: teduglutide (0.10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teduglutide (0.10 mg/kg/d)
Trial: 10892359
Drug: Invasive surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive surgical treatments for acute myocardial infarction
Trial: 9001926
Drug: Metered Dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered Dose Inhaler (MDI) - nedocromil sodium 4 mg + salbutamol 0.2 mg
Trial: 9001926
Drug: Nebulizer Solution
RxNorm normalized name: Intal 20mg/2ml Nebulizer Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer Solution - nedocromil sodium 10 mg + salbutamol 1.5 mg
Trial: 9001926
Drug: Nebulizer Solution
RxNorm normalized name: Intal 20mg/2ml Nebulizer Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer Solution
Trial: 6424240
Drug: Daily topical
RxNorm normalized name: Clindagel 1 % Once-Daily Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily topical applications of povidone‐iodine
Trial: 29273946
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU), standard referral to treatment
Trial: 26221051
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (sham)
Trial: 23185756
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal enema therapy (CHET), once daily for 2 weeks as one therapeutic course
Trial: 23185756
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal enema therapy (CHET)
Trial: 23185756
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal enema therapy (CHET) and basic treatment
Trial: 20397286
Drug: Bupropion XL
RxNorm normalized name: Bupropion Hydrochloride 150 MG Oral Tablet, Extended Release [BUPROPION XL]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion XL 300 mg
Trial: 16335686
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment (subgroup AII)
Trial: 16335686
Drug: Sulfonylurea treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea treatment (subgroup AI)
Trial: 2403227
Drug: 0.1 mL
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mL influenza vaccine
Trial: 2403227
Drug: 0.05 mL
RxNorm normalized name: xenon 0.05 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mL influenza vaccine
Trial: 2403227
Drug: 0.5 mL
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mL influenza vaccine
Trial: 2403227
Drug: 0.1 mL
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mL and 0.05 mL influenza vaccine
Trial: 630187
Drug: ioglycamide (Biligram)
RxNorm normalized name: ioglycamic acid
DrugBank: Ioglycamic acid (DB13741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ioglycamide (Biligram) at 3 mg/kg/min for one hour
Trial: 630187
Drug: ioglycamide (Biligram)
RxNorm normalized name: ioglycamic acid
DrugBank: Ioglycamic acid (DB13741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ioglycamide (Biligram) at 4 mg/kg/min for one hour
Trial: 630187
Drug: ioglycamide (Biligram)
RxNorm normalized name: ioglycamic acid
DrugBank: Ioglycamic acid (DB13741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ioglycamide (Biligram) at 2 mg/kg/min drip infusion
Trial: 630187
Drug: ioglycamide (Biligram)
RxNorm normalized name: ioglycamic acid
DrugBank: Ioglycamic acid (DB13741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ioglycamide (Biligram) by 10 minute slow hand injection
Trial: 21460356
Drug: Oxabact (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxabact (oral administration)
Trial: 18087163
Drug: Omalizumab at
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab at a dose of >=0.016 mg/kg/IgE every 4 weeks
Trial: 16291387
Drug: PCEA (ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCEA (ropivacaine 3.2 mg + fentanyl 8 microg/dose)
Trial: 16291387
Drug: IV-PCA (morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV-PCA (morphine 2 mg/dose)
Trial: 10460982
Drug: 14‐day training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14‐day training of a relaxation therapy including a 30‐minute lullaby‐like, rhythmically dominated music with gradually decreasing tempi
Trial: 8529732
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac 50 mg 3 times a day for 7 days
Trial: 619075
Drug: HPV‐77 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV‐77 vaccine
Trial: 619075
Drug: RA‐27/3 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA‐27/3 vaccine (subcutaneously)
Trial: 619075
Drug: RA‐27/3 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA‐27/3 vaccine (intranasally)
Trial: 619075
Drug: RA‐27/3 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA‐27/3 vaccine
Trial: 23928094
Drug: BIIB023 (0.03-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIIB023 (0.03-20 mg/kg)
Trial: 11573658
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at 2 microg ml(‐1) with two word lists (category examples and nonsense words)
Trial: 11573658
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at 5 microg ml(‐1) with nonsense words before tracheal intubation and category examples during intubation
Trial: 11573658
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at 5 microg ml(‐1) with category examples before and nonsense words during intubation
Trial: 9591926
Drug: 40 microg
RxNorm normalized name: Travoprost 40 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 microg from a metered‐dose inhaler plus spacer
Trial: 7846921
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg b.i.d. with preoperative cathartic (group OA, n = 159)
Trial: 7846921
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral antibiotic (group NOA, n = 168)
Trial: 20924294
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion morphine
Trial: 20924294
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion morphine with Bupivacaine
Trial: 31571329
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT) programme (12 sessions)
Trial: 16051499
Drug: Threshold therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Threshold therapy with 30% load
Trial: 11518831
Drug: GH dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH dosage group A, 4 IU/m(2)/d
Trial: 11518831
Drug: GH dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH dosage group B, first year 4 IU/m(2)/d, thereafter 6 IU/m(2)/d
Trial: 11518831
Drug: GH dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH dosage group C, first year 4 IU/m(2)/d, second year 6 IU/m(2)/d, thereafter 8 IU/m(2)/d
Trial: 9625091
Drug: Olestra (20-35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olestra (20-35 g)
Trial: 7933659
Drug: 1800 mg
RxNorm normalized name: glycerin 1800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1800 mg IPA-E
Trial: 7933659
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg IPA-E
Trial: 7933659
Drug: Control (pre-administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (pre-administration values)
Trial: 2463717
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg metoprolol per day
Trial: 2661389
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg metoprolol per day
Trial: 30141180
Drug: Cinacalcet (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet (0.25 mg/kg)
Trial: 28346377
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of UCA and randomized beamforming scheme
Trial: 15567053
Drug: TFL-assisted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TFL-assisted treatment group
Trial: 11763512
Drug: Trisekvens plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trisekvens plus betaksolol (10‐20 mg/day)
Trial: 30477210
Drug: Intensive oral
RxNorm normalized name: Uricalm Intensive Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive oral health instruction at baseline and self-assessment every three months
Trial: 30477210
Drug: Intensive oral
RxNorm normalized name: Uricalm Intensive Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive oral health instruction
Trial: 27345158
Drug: E2/NETA (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/NETA (1 mg estradiol and 0.5 mg norethisterone acetate)
Trial: 9251452
Drug: Sodium Nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium Nitroprusside (SNP) added peritoneal dialysis (PD) with 36 cycles of intermittent PD, exchange volume of 1 litre, duration of 1 hour per cycle, SNP dose of 4 mg/litre in alternate clearance periods.
Trial: 6698337
Drug: Aspirin treatment
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin treatment (2 g per day for one week)
Trial: 6698337
Drug: Aspirin vs.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin vs. Lysine acetylsalicylate
Trial: 17846548
Drug: Sinus augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinus augmentation with 100% autologous bone
Trial: 17846548
Drug: Sinus augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinus augmentation with 100% Bio‐Oss
Trial: 11779741
Drug: Oral jaw-positioning
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral jaw-positioning appliance (6-month trial)
Trial: 9678813
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg b.d. plus clarithromycin 250 mg t.d.s. and tinidazole 500 mg b.d. (group RBCCT)
Trial: 9678813
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg b.d. plus clarithromycin 250 mg t.d.s. plus amoxycillin 1 g b.d. (group RBCCA)
Trial: 7862890
Drug: Nicotine injections
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine injections (0.6 mg, subcutaneous, two injections 40 min apart)
Trial: 19925973
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic plus buprenorphine 0.3 mg
Trial: 17000354
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine treatment
Trial: 17000354
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between morphine-treated group and controls
Trial: 12680861
Drug: Sublingual-swallow immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual-swallow immunotherapy (SLIT) with standardized Dermatophagoides pteronyssinus (D.pt.) and D. farinae (D.f.) 50/50 extract
Trial: 12680861
Drug: Sublingual-swallow immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual-swallow immunotherapy (SLIT)
Trial: 1559524
Drug: Low-density (LD)
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-density (LD) diet (50 kcal/100 g)
Trial: 1559524
Drug: High-density (HD)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-density (HD) diet (100 kcal/100 g)
Trial: 28003127
Drug: Propranolol administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol administered 60-75 minutes before learning or recall
Trial: 28003127
Drug: Propranolol administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol administered immediately after learning or recall
Trial: 23702185
Drug: Neonatal Vitamin
RxNorm normalized name: NEONATAL VITAMIN Tablet
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neonatal Vitamin A Supplementation (VAS) with BCG vaccine
Trial: 23702185
Drug: Neonatal Vitamin
RxNorm normalized name: NEONATAL VITAMIN Tablet
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neonatal Vitamin A Supplementation (VAS) without BCG vaccine
Trial: 23702185
Drug: Neonatal Vitamin
RxNorm normalized name: NEONATAL VITAMIN Tablet
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neonatal Vitamin A Supplementation (VAS) among children who had not received DTP vaccine
Trial: 23702185
Drug: Neonatal Vitamin
RxNorm normalized name: NEONATAL VITAMIN Tablet
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neonatal Vitamin A Supplementation (VAS) among children who had received DTP vaccine
Trial: 12957348
Drug: Integrated Family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Family and Cognitive‐Behavioral Therapy (IFCBT)
Trial: 12957348
Drug: Drugs Harm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs Harm Psychoeducation curriculum (DHPE)
Trial: 11138645
Drug: High-potency, high-frequency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-potency, high-frequency fluoride brush-on gel
Trial: 11138645
Drug: High-potency, high-frequency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-potency, high-frequency fluoride gel dentifrice
Trial: 10778622
Drug: Selegiline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (10 mg per day)
Trial: 30127143
Drug: After two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: After two injections
Trial: 27515871
Drug: Spiritist 'passe'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiritist 'passe' energy therapy (8 weekly sessions)
Trial: 27515871
Drug: Sham Spiritist
RxNorm normalized name: TURPENTINE SPIRITS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham Spiritist 'passe' sessions (8 weekly sessions)
Trial: 27515871
Drug: Spiritist 'passe'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiritist 'passe' energy therapy
Trial: 18317456
Drug: Glutamine-enriched parenteral
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-enriched parenteral nutrition (GlPN, n=27)
Trial: 18317456
Drug: Standard parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard parenteral nutrition (PN, n=26)
Trial: 16503885
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate (0.05%) cream twice daily
Trial: 16503885
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment (0.005%) twice daily
Trial: 16503885
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of betamethasone dipropionate (0.05%) in the morning and calcipotriol (0.005%) in the evening
Trial: 11153584
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil capsules containing 84 mg eicosapentaenoic acid (EPA) and 36 mg docosahexaenoic acid (DHA)
Trial: 11153584
Drug: Control capsules
RxNorm normalized name: Azo Men Bladder Control Capsules(obs)
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control capsules containing 300 mg olive oil
Trial: 2945833
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of KOB and buddy programs
Trial: 29135277
Drug: Neuromuscular Manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular Manual Therapy (NMT)
Trial: 29135277
Drug: Standard Pharmacological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Pharmacological Treatment (PT)
Trial: 24647231
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate 1000mg plus prednisone 5mg twice daily
Trial: 18678158
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Fenbid slow-released capsules
Trial: 20499152
Drug: Risky sexual
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risky sexual behaviors within a couple and with concurrent sexual partners
Trial: 9876949
Drug: 720 ELISA
RxNorm normalized name: hepatitis A virus vaccine 720 ELISA unit/0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 720 ELISA Units (EL.U) inactivated hepatitis A vaccine, 0, 6‐month schedule
Trial: 9876949
Drug: 360 ELISA
RxNorm normalized name: hepatitis A virus vaccine 360 ELISA unit/0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 ELISA Units (EL.U) inactivated hepatitis A vaccine, 0, 1, 6‐month schedule
Trial: 7978126
Drug: Endotoxin antibody
RxNorm normalized name: endotoxin antibody Ha-1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endotoxin antibody (hypothetical intervention)
Trial: 29927386
Drug: AL-794 (50-2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL-794 (50-2000 mg single ascending doses)
Trial: 29927386
Drug: AL-794 (50-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL-794 (50-600 mg multiple ascending doses, twice-daily)
Trial: 29927386
Drug: AL-794 (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL-794 (450 mg following a high-fat meal)
Trial: 22730693
Drug: Xuebejing injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuebejing injection combined with conventional therapy
Trial: 20299778
Drug: Intravesically applied
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesically applied amikacin (1 g in adults and 30 mg/kg in pediatric patients)
Trial: 17195701
Drug: Single-dose ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose ceftriaxone
Trial: 17195701
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics (cefprozil, amoxicillin, azithromycin)
Trial: 2200997
Drug: Cefotiam 1
RxNorm normalized name: cefotiam
DrugBank: Cefotiam (DB00229)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotiam 1 g preoperative dose